JP2011518843A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518843A5
JP2011518843A5 JP2011506486A JP2011506486A JP2011518843A5 JP 2011518843 A5 JP2011518843 A5 JP 2011518843A5 JP 2011506486 A JP2011506486 A JP 2011506486A JP 2011506486 A JP2011506486 A JP 2011506486A JP 2011518843 A5 JP2011518843 A5 JP 2011518843A5
Authority
JP
Japan
Prior art keywords
group
compound
alkyl
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506486A
Other languages
English (en)
Japanese (ja)
Other versions
JP5599385B2 (ja
JP2011518843A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041715 external-priority patent/WO2009132307A1/en
Publication of JP2011518843A publication Critical patent/JP2011518843A/ja
Publication of JP2011518843A5 publication Critical patent/JP2011518843A5/ja
Application granted granted Critical
Publication of JP5599385B2 publication Critical patent/JP5599385B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506486A 2008-04-24 2009-04-24 アンドロゲンレセプターの小分子阻害剤 Expired - Fee Related JP5599385B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4755908P 2008-04-24 2008-04-24
US61/047,559 2008-04-24
PCT/US2009/041715 WO2009132307A1 (en) 2008-04-24 2009-04-24 Small-molecule inhibitors of the androgen receptor

Publications (3)

Publication Number Publication Date
JP2011518843A JP2011518843A (ja) 2011-06-30
JP2011518843A5 true JP2011518843A5 (enExample) 2012-06-14
JP5599385B2 JP5599385B2 (ja) 2014-10-01

Family

ID=41217163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506486A Expired - Fee Related JP5599385B2 (ja) 2008-04-24 2009-04-24 アンドロゲンレセプターの小分子阻害剤

Country Status (8)

Country Link
US (2) US8354538B2 (enExample)
EP (1) EP2276345A4 (enExample)
JP (1) JP5599385B2 (enExample)
KR (1) KR101640512B1 (enExample)
AU (1) AU2009240417B2 (enExample)
CA (1) CA2722340A1 (enExample)
NZ (1) NZ589299A (enExample)
WO (1) WO2009132307A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2496135B (en) * 2011-11-01 2015-03-18 Valirx Plc Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis
WO2014130932A2 (en) * 2013-02-25 2014-08-28 Novartis Ag Novel androgen receptor mutation
GB2513615A (en) 2013-05-01 2014-11-05 Cancer Rec Tech Ltd Medical use
US10428048B2 (en) 2015-09-04 2019-10-01 City Of Hope Androgen receptor antagonists
WO2019126739A1 (en) 2017-12-21 2019-06-27 Shepherd Therapeutics, Inc. Pyrvinium pamoate anti-cancer therapies
WO2019152731A1 (en) * 2018-01-31 2019-08-08 Alpine Androsciences, Inc. Androgen receptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166538A (en) * 1967-06-10 1969-10-08 Pfizer Ltd Substituted Tetrahydroquinolines
DE2421382A1 (de) 1974-05-03 1975-11-20 Council Scient Ind Res 1-substituierte 4-(beta-2-chinolylaethyl)- piperazine und deren 1,2,3,4-tetrahydrochinolinanaloge
US3983121A (en) * 1974-07-01 1976-09-28 Council Of Scientific And Industrial Research 1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof
US5840500A (en) * 1996-07-11 1998-11-24 Trega Biosciences, Inc. Quinoline derivatives and quinoline combinatorial libraries
KR100826485B1 (ko) * 1999-10-14 2008-05-02 가켄 세야쿠 가부시키가이샤 테트라히드로퀴놀린 유도체
EP1325914A4 (en) 2000-09-14 2004-11-17 Kaken Pharma Co Ltd TETRAHYDROQUINOLINE COMPOUNDS
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
WO2005090282A1 (en) * 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US7482359B2 (en) * 2004-08-25 2009-01-27 Merck & Co., Inc. Androgen receptor modulators
US20080281105A1 (en) 2005-01-18 2008-11-13 Immusol Incorporated Novel Quinolinium Salts and Derivatives
WO2007117466A2 (en) 2006-03-31 2007-10-18 Massachusetts Institute Of Technology Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
WO2008128100A1 (en) * 2007-04-13 2008-10-23 The Regents Of The University Of California Small-molecule inhibitors of the androgen receptor

Similar Documents

Publication Publication Date Title
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
JP2009534386A5 (enExample)
JP2013507425A5 (enExample)
JP2009516697A5 (enExample)
JP2011518843A5 (enExample)
JP2013510120A5 (enExample)
JP2010524932A5 (enExample)
JP2010529147A5 (enExample)
EA201171333A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-с-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
JP2012533546A5 (enExample)
JP2005517006A5 (enExample)
JP2009523760A5 (enExample)
JP2014508804A5 (enExample)
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
JP2012513416A5 (enExample)
JP2010501478A5 (enExample)
JP2011513475A5 (enExample)
RU2009144538A (ru) Новые циклические пептидные соединения
JP2013537198A5 (enExample)
JP2011506566A5 (enExample)
JP2008534453A5 (enExample)
JP2018536678A5 (enExample)
NZ596820A (en) Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
JP2017511368A5 (enExample)
JP2007517007A5 (enExample)